Medicus Pharma (MDCXW) Stock: Why It's Down Today
Updated Oct 21, 2026, 4:00 PM ET · closing price
- Latest session (Wed Oct 21): $0.21, −$0.08 (-27.59%), volume 0.3x its 50-day average.
- Latest SEC filing: PRE 14A on Oct 19, 2026.
Sector peers moving today (Pharma & Biotech):TKNO -20.84%RCUS -19.58%CYPH +18.51%HURA +18.47%RAPP -14.67%
- Closed at $0.21, -27.59% vs the prior close of $0.29.
- Volume 602 shares, 0.3x its 50-day average (light).
- New SEC filings: PRE 14A (Oct 19, 2026), 424B3 (Oct 16, 2026), 8-K (Oct 16, 2026), SCHEDULE 13G/A (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)
MDCXW slides 27.6% to $0.21. Closed at $0.21, -27.59% vs the prior close of $0.29. Day range $0.21–$0.21, opened at $0.99.
Why Did MDCXW Stock Move Today?
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 21, 2026 — MDCXW slides 27.6% to $0.21
- Closed at $0.21, -27.59% vs the prior close of $0.29. Day range $0.21–$0.21, opened at $0.99.
- Volume was 602 shares, 0.3x its 50-day average of 2.37K — lighter than usual.
- 52-week range $0.20–$0.29; today's close sits at 11% of that range, 27.6% below the 52-week high.
MDCXW bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Latest fiscal-year net income: loss of $47.28M.
- Share count up 254.6% in a year (dilution).
- High volatility: average daily move of 27.6% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
Latest MDCXW SEC 8-K & 10-Q Filings
Every SEC filing by or about MDCXW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Oct 16, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Oct 16, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 7, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 14, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade MDCXW
- How much it moves: over the last 20 sessions the average daily move was 27.59% (largest 27.6%). That is a volatile stock.
- Liquidity: about 1.48K shares (≈$312) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.21 vs a range of $0.20–$0.29 (11% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 7, 2026; 8-K Sep 14, 2026.
- Share count: 63.18M shares outstanding (Aug 10, 2026), +254.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MDCXW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | 0.99 | 0.21 | 0.21 | 0.21 | 602 |
| Oct 16, 2026 | 0.99 | 0.29 | 0.20 | 0.29 | 2.37K |
About Medicus Pharma
Medicus Pharma (MDCXW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in W. CONSHOHOCKEN, PA. State of incorporation: Ontario, Canada. Fiscal year ends December 31. SEC CIK 1997296.
MDCXW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William Ashton | Director | Jun 4, 2026 |
| Raza Bokhari | Chief Executive Officer | Sep 8, 2026 |
| Robert J. Ciaruffoli | Director | Jun 4, 2026 |
| Barry Fishman | Director | Jun 4, 2026 |
| Larry Kaiser | Director | Jun 4, 2026 |
| Patrick J Mahaffy | Director | Jun 4, 2026 |
| Sara R. May | Director | Jun 4, 2026 |
| Ajay Raju | Director | Jun 4, 2026 |
| Cathy Mcmorris Rodgers | Director | Jun 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Raza Bokhari | Chief Executive Officer | Sep 8, 2026 |
| Carolyn F. Bonner | President and CFO | Sep 8, 2026 |
| Edward J. Brennan | Chief Scientific Officer | Sep 8, 2026 |
| Faisal Mehmud | Chief Medical Officer | Sep 8, 2026 |
| Andrew Alasdair Smith | Chief Operating Officer | Sep 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MDCXW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-47.28M | -2.74 | $-22.78M |
| Dec 31, 2024 | — | $-11.16M | -1.16 | $-10.25M |
| Dec 31, 2023 | — | $-5.31M | -1.53 | $-4.16M |
Latest balance sheet: total assets $27.12M, total liabilities $28.84M, cash $15.17M (as of Jun 30, 2026).
MDCXW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Space Exploration Technologies (SPCX)Meta Platforms (META)Tesla (TSLA)Apple (AAPL)Sandisk (SNDK)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on MDCXW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 21, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.